CWM
GILD icon

Congress Wealth Management’s Gilead Sciences GILD Stock Holding History

Congress Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$11.2M Buy
100,734
+76,119
+309% +$8.1M 0.11% 227
2025
Q1 		$2.74M Sell
24,615
-103
-0.4% -$10.6K 0.03% 433
2024
Q4 		$2.28M Sell
24,718
-45,890
-65% -$4.13M 0.03% 391
2024
Q3 		$5.92M Buy
70,608
+41,757
+145% +$3.19M 0.08% 270
2024
Q2 		$1.98M Buy
28,851
+23,531
+442% +$1.57M 0.03% 359
2024
Q1 		$390K Sell
5,320
-652
-11% -$50.1K 0.01% 477
2023
Q4 		$484K Buy
5,972
+371
+7% +$28.9K 0.01% 470
2023
Q3 		$420K Buy
5,601
+1,204
+27% +$92.6K 0.01% 478
2023
Q2 		$339K Buy
4,397
+61
+1% +$4.87K 0.01% 468
2023
Q1 		$360K Sell
4,336
-131
-3% -$10.8K 0.01% 460
2022
Q4 		$384K Buy
4,467
+196
+5% +$15.5K 0.01% 444
2022
Q3 		$264K Sell
4,271
-1
-0% -$63 0.01% 486
2022
Q2 		$264K Sell
4,272
-276
-6% -$17.1K 0.01% 494
2022
Q1 		$270K Sell
4,548
-1,230
-21% -$78.6K 0.01% 531
2021
Q4 		$419K Buy
+5,778
New +$398K 0.01% 488

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Congress Wealth Management's GILD Position: Q2 2025 in Review

Congress Wealth Management increased its Gilead Sciences (GILD) stake by 309% in Q2 2025, buying an estimated $8.1M and bringing the position to 100,734 shares worth $11.2M. The position accounts for 0.11% of the portfolio, ranked #227.

Congress Wealth Management first reported a position in GILD in Q4 2021 and has held it in 15 quarters since. 2,026 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Congress Wealth Management held 100,734 shares of Gilead Sciences worth $11.2M as of Q2 2025.
  • Congress Wealth Management bought 76,119 Gilead Sciences shares in Q2 2025, an estimated $8.1M.
  • Gilead Sciences made up 0.11% of Congress Wealth Management's portfolio in Q2 2025, its #227 holding.
  • Congress Wealth Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 15 quarters since.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.